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Abstract
Dysfunction of Paneth and goblet cells in the intestine contributes to inflammatory bowel disease (IBD) and colitis-
associated colorectal cancer (CAC). Here, we report a role for the NAD+-dependent histone deacetylase SIRT1 in the control
of anti-bacterial defense. Mice with an intestinal specific Sirt1 deficiency (Sirt1int2/2) have more Paneth and goblet cells with
a consequent rearrangement of the gut microbiota. From a mechanistic point of view, the effects on mouse intestinal cell
maturation are mediated by SIRT1-dependent changes in the acetylation status of SPDEF, a master regulator of Paneth and
goblet cells. Our results suggest that targeting SIRT1 may be of interest in the management of IBD and CAC.
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Introduction
Paneth and goblet cells are highly specialized small intestinal
epithelial cells that synthesize and secrete anti-microbial peptides
and mucus. These factors represent the first line of defense against
pathogens and are essential to maintain the subtle balance among
different bacterial species that colonize the mammalian gut [1].
Dysbiotic microbiota impact on the health of the host and
contribute to the pathogenesis of several intestinal diseases, such as
inflammatory bowel disease (IBD) and colitis-associated colorectal
cancer (CAC) [2].
The differentiation and maturation of Paneth and goblet cells
is controlled by the Wnt and Notch signaling cascades that
cooperate to promote the specification of the different cell lineages
[3]. Moreover, the SAM pointed domain containing ETS
transcription factor (SPDEF), a downstream effector of both Wnt
and Notch pathways, is known to enhance the differentiation of
both Paneth and goblet cells from their common progenitor [4].
SPDEF was initially identified as a regulator of the prostate-
specific antigen [5], but later also associated to breast, lung, and
intestine epithelium, with possible involvement in cancer progres-
sion in those tissues [6,7].
Sirtuin 1 (SIRT1), a NAD+-dependent deacetylase [8], is
involved in a wide range of cellular processes including metabo-
lism, cell proliferation and apoptosis, and immune response [9].
The role of SIRT1 in the regulation of intestinal homeostasis is
only beginning to be elucidated. Recently an involvement of
intestinal SIRT1 in systemic bile acid and cholesterol metabolism
has been proposed [10]. Furthermore, studies focusing on the role
of SIRT1 in colorectal cancer development using Apcmin/+mice as
a model, showed conflicting results supporting both tumor
promoting [11] and tumor suppressing [12,13] functions.
Using mice with an intestinal-specific Sirt1 deletion (Sirt1int2/2),
we show here that SIRT1 regulates Paneth and goblet cell
maturation and production of anti-bacterial proteins. These effects
depend on SIRT1-mediated changes in the acetylation status of
SPDEF. Moreover, intestinal Sirt1 deletion has a major impact on
the gut microbiome and protects mice from IBD and CAC.
Notably, the effects of Sirt1 deficiency on the production of anti-
bacterial proteins are evolutionary conserved in C.elegans high-
lighting the ancient nature of this function of SIRT1. Taken
together our results suggest that targeting SIRT1 may be of
interest for the management of IBD and CAC.
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Materials and Methods
Generation of Sirt1int2/2 and Sirt1int2/2
-LGR5EGFP-ires-CRE-ert2 mice
For the generation of Sirt1 floxed (Sirt1L2/L2) mice, genomic
DNA covering the Sirt1 locus was amplified from the 129Sv strain
by high-fidelity PCR. The resulting DNA fragments were
assembled into the targeting vector of the Institut Clinique de la
Souris (Strasbourg, France). The construct in which exons 5, 6 and
7 were flanked by LoxP sites was then electroporated into 129Sv
embryonic stem (ES) cells (Figure S1B). G418-resistant colonies
were selected and analyzed for homologous recombination by
PCR and positive clones were verified by Southern blot
hybridization. Correctly targeted ES cell clones were injected into
blastocysts and transferred into pseudopregnant females, resulting
in chimeric offspring that were mated to female C57BL/6J mice
that express the Flp recombinase under the control of the
ubiquitous cytomegalovirus promoter [14]. Offspring that trans-
mitted the mutated allele and that lost the Flp transgene (Sirt1L2/WT
mice) were then selected, and backcrossed to C57BL/6J mice for
ten generations. For the gut microbiota analysis Sirt1int2/2 and
Sirt1L2/L2 were co-housed under specific pathogen free conditions
within the same room. Mice treated with AOM/DSS were singly
housed after weaning to avoid differences in the DSS intake.
However, Sirt1int2/2 and Sirt1L2/L2 were treated under specific
pathogen free conditions within the same room. Notably, Sirt1int2/2
and Sirt1L2/L2 mice come from the same parents. All animal
experiments were done in accordance with institutional and Swiss
guidelines and approved by the Cantonal authorities of the Canton
of Vaud. Moreover, all animal experiments were conformed to the
Swiss Animal Welfare legislation and reviewed by the State Ethical
Board of the Canton de Vaud (Animal Welfare Act 2005; Project
License Nu 2463-2463.1-2605 license to Prof. Johan Auwerx).
Finally, all animal experiment were approved by the independent
State of Vaud Veterinary office ethical board, which acts in
compliance with the Animal Welfare Act, the AAALAC interna-
tional guidelines, the Swiss and EU legislation. Mice were
euthanatized using a brief exposure to CO2. This method leads to
quick and painless asphyxiation in mice. All the experiments were
carried out from October 2011 to April 2014.
Plasmids
Mammalian expression vector pUSE-SIRT1 was purchased
from Upstate. The SPDEF coding sequence belongs to the Mouse
Transcription Factor Resource [15]. It was amplified and ligated
to the pCDNA3-FLAG or pGEX-GST. pCruzHA SIRT1G261A
(plasmid 10963) [16] and pGL2Basic-EcadK1 (plasmid 19290)
[17] were purchased by Addgene. pGEX-GST- SPDEFK294Q
was generated using site-directed mutagenesis.
C.elegans assays
C.elegans strains were grown at 20uC on nematode growth media
agar plates (NGM) seeded with E. coli strain OP50 unless stated
otherwise. Strains used were wild-type Bristol N2, VC199 sir-
2.1(ok434) IV, SAL129 [pha-1(e2123)III;lys-1::GFP+pha-1(+)], and
SAL105 [pha-1(e2123)III;lys-7::GFP+pha-1(+)]. Strains were pro-
vided by the Caenorhabditis Genetics Center (University of
Minnesota). Bacterial feeding RNAi experiments were carried
out as described [18]. The sir-2.1 (R11A8.4) clone was purchased
from GeneService and sequenced. Quantification of GFP expression
was carried out according to described protocols [19]. For picture
acquisition of lys-7::GFP expression, animals were mounted on 2%
agarose pads in 10 mM tetramisole (Sigma) and examined using a
Zeiss Axioplan-2 microscope (Carl Zeiss).
mRNA extraction and RT-qPCR analysis
RNA was isolated from tissues using the TriPure reagent
(Roche) according with manufacturer’s instructions. cDNA was
generated from 1 mg of total RNA using QuantiTect Reverse
Transcription Kit (Qiagen). qRT-PCR was carried out using
LightCycler 480 SYBR Green I Master Mix (Roche) and analyzed
through DDCT calculation. Values were normalized to Cyclophi-
lin expression. Primers are listed in Table S1 in File S1.
Luciferase assay
PC3 cells (ATCC) in 96/wells plates were co-transfected with a
reporter containing the SPDEF response element of the human E-
cadherin promoter, pGL2Basic-EcadK1 and pcDNA3, pCDA3-
FLAG-SPDEF or pCDA3-FLAG-SPDEFK294Q with or without
pUSE-SIRT1 expression vectors (jetPEI transfection; Polyplus).
Media was removed after 24 hr, cells washed with cold PBS, and
Luciferase Substrate (Bright-Glo Luciferase Assay System, Pro-
mega) was added before Luciferase measurement by the Victor
63. b-galactosidase was used for normalization.
In vitro acetylation and deacetylation assays
In vitro acetylation and deacetylation assays were performed as
originally described [20]. Briefly, 1 mg of recombinant SPDEF
protein, obtained from the BL21 strain, were incubated with
500 ng of recombinant p300 in acetylation buffer (50 mM Tris-
HCl, pH 8, 100 mM NaCl, 10% glycerol, 1 mM PMSF, 1 mM
DTT, 1 mg/ml bepstatin, 1 mg/ml leupeptin, 1 mg/ml pepstatin,
1 mM sodium butyrate and 150 mM acetyl-CoA) for 1 hour at
30uC. After incubation, samples were resolved on SDS-PAGE and
analyzed by western blot or used for in vitro deacetylation assays.
For deacetylation assays, 1 mg of acetylated SPDEF was incubated
with 500 ng recombinant SIRT1 protein in deacetylation buffer
(50 mM Tris-HCl, pH 9, 4 mM MgCl2, 0.2 mM DTT, 1 mg/ml
bepstatin, 1 mg/ml leupeptin, 1 mg/ml pepstatin, and 1 mM
NAD+) for 30 minutes with constant agitation. The incubated
samples were resolved on SDS-PAGE and analyzed by western
blot or used to map an acetylated residue with nano-LC-MS/MS.
Recombinant p300, SIRT1, SIRT6, and SIRT7 proteins were
made by Dr. Michael O. Hottiger (University of Zurich). Cell
based deacetylation was assayed in Hek293T cells transfected by
pCDA3-FLAG-SPDEF or pCDA3-FLAG-SPDEFK294Q with or
without pUSE-SIRT1 or pCruzHA-SIRT1G261A expression
vectors by jetPEI Transfection kit (Polyplus). 22 hours later,
media was replaced with fresh media (Dulbecco’s modified Eagle’s
medium with 4.5 g/l glucose, 10% fetal calf serum, 0.1 mM
NEAA, 50 mg/ml gentamicin and 1 mM sodium butyrate). After
2 hours, whole cell-lysates were prepared using IP lysis buffer
(50 mM Tris HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1%
TRITON X-100, 10 mM sodium butyrate and 10 mM nicotin-
amide) supplemented with Complete Protease Inhibitor Cocktail
Tablets (Roche). 0.5 mg to 1 mg of whole cell-lysates was used for
immunoprecipitation (IP). IP was performed with FLAG-Agarose
Affinity Gel as described by the supplier (A2220, Sigma-Aldrich).
After IP, samples were applied to SDS-PAGE and analyzed by
western blotting.
Cell culture, transfection, and antibodies
HEK293 and PC3 cells were cultured in Dulbecco’s modified
Eagle’s medium including 4.5 g/l glucose, 10% fetal calf serum,
0.1 mM NEAA and 50 mg/ml gentamicin at 37uC under a 5%
CO2 atmosphere. HEK293T and PC3 cells were transfected using
JetPei reagent (Polyplus Transfections, Illkirch, France) according to
the manufacturer’s instructions. Antibodies: Lysozyme (Abcam,
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Ab36362), ChRA (Santa Cruz, sc-13090), Acetylated lysine (Cell
signaling, 9441L), Sirt1 (Abcam, ab12193), b-catenin (Sigma,
A5441), L-FABP (Santa Cruz, sc-50380), PCNA (Santa Cruz, sc-
56), HSP90 (BD Transduction Laboratories, 610418), anti-FLAG
(Sigma, F1804), Tubulin (Santa Cruz, sc-5286), SPDEF for
western blot (Sigma, AV32533), SPDEF for IHC was kindly
provided by Prof. J. Whitsett.
Subcellular fractionation
Cytoplasm and nucleoplasm fractions were obtained from
Sirt1L2/L2 and Sirt1int2/2 isolated crypt. Crypts were isolated
following a published protocol [21]. Single crypt-derived cells were
finally washed with ice-cold PBS, and incubated in buffer A
(10 mM KCl, 1.5 mMMgCl2, 0.5 mM DTT10 mM, 10 HEPES-
KOH, pH 7.4) including a proteinase inhibitor cocktail (Roche)
for 5 min. After 50 strokes in a dounce homogenizer, cytoplasm
fraction was collected by centrifugation (1.4 k6g for 5 min, 4uC).
Pellets were washed two times with buffer A. Nuclei were
incubated in buffer B (150 mM NaCl, 0.1% NP-40, 50 mM
Tris-HCl, pH 7.4) containing a proteinase inhibitor cocktail for
30 min on ice. Nucleoplasm was collected by centrifugation (2 k6
g for 5 min, 4uC). Proteins were quantified using the Lowry
method and processed for western blot assay.
GFP+ cells analysis
Crypts from Sirt1L2/L2- and Sirt1int2/2-LGR5EGFP-ires-CRE-ert2
intestines were isolated as previously described (see Subcellular
fractionation paragraph) [22]. Single cells were analyzed by FACS to
detect the GFP+ cells.
Fractionation of cells along the crypt–villus axis
The sequential isolation of mouse small intestinal epithelial cells
along the crypt–villus axis was performed as described previously
[23] with few modifications. Briefly, the entire small intestine
(duodenum to terminal ileum) was removed, flushed, and cut in
small pieces (2–5 mm) and incubated at 37uC for 15 min in 15 ml
of buffer A (96 mM NaCl, 1.5 mM KCl, 27 mM Na-citrate,
8 mM KH2PO4, and 5.6 mM Na2HPO4, pH 7.3). Then it was
incubated for 10 min in 15 ml of buffer B (PBS plus 1.5 mM
EDTA, 0.5 mM dithiothreitol, and 1 mg/ml bovine serum
albumin) in a shaking 37uC incubator. At the completion of the
15-minute incubation, detached enterocytes were collected (Frac-
tion 1) and 15 ml of fresh buffer B added to the tissue. This
procedure was repeated four more times, the steps lasting 25, 25,
25 and 30 min, respectively (Fractions 2, 3, 4 and 5), for a total of
120 min of incubation time. At the completion of the final
incubation period, cells collected from each of the 5 fractions were
harvested by centrifugation at 1500 rpm at 4uC for 5 min. Cell
pellets were washed twice and lysed in RIPA buffer. Alkaline
phosphatase activity was assayed by Alkaline Phosphatase Assay
kit (BioVision).
Mass spectrometry analysis
Gel lanes were cut into pieces and subjected to in-gel digestion
with endoproteinase Glu-C or trypsin. Peptide digests were
resuspended and analyzed by nano-LC-MS/MS using an Orbi-
trap Elite mass Spectrometer (Thermo Fischer Scientific) coupled
to an ultraperformance LC (UPLC) system (Thermo Fischer
Scientific Ultimate 3000 RSLC). Data analysis was performed
with Proteome Discoverer (v. 1.3) and searches were performed
with Mascot and Sequest against a mouse database (UniProt
release 2013_01). Data were further processed, inspected and
visualized using Scaffold 3 software.
In situ hybridization
The in situ probes used in this study correspond to expressed
sequence tags or fully sequenced cDNAs obtained from Open
Biosystems. The accession numbers for these probes are as follows:
mouse Olfm4 BC141127 (9055739), mouse Defa4 BC134360
(40134597). To ensure the specificity of the probes, we generated
both sense and antisense probes by in vitro transcription using DIG
RNA labeling mix (Roche) according to the manufacturer’s
instructions and to published methods [24]. ISH was done using
the fully automated instrument Ventana XT (Roche). Chemicals
were from Roche Diagnostics. Briefly, formalin fixed paraffin-
embedded sections were de-paraffinized and rehydrated and
pretreated by enzymatic digestion (protease1, 4 min at 37uC).
Hybridization was performed adding to each slide 50 or 100 ng of
the probe diluted in Ribohybe at 65uC for 6 hours.
Bactericidal assay
Bactericidal assays were carried out as described [25] with few
modifications. Briefly, the small intestine of adult mice was rinsed
with ice-cold PBS and segments incubated in 30 mM EDTA to
elute epithelial cells. Total proteins from the epithelial cells were
extracted using NP40 lysis buffer (20 mM Tris pH 7.4, 150 mM
NaCl, 2.5 mM KCl, 5 mM EDTA, 5% [vol/vol] glycerol, 1%
[vol/vol] NP40) supplemented with complete protease inhibitor.
100 mg of proteins were incubated for 60 minutes at 37uC in
10 mM iPIPES buffer containing exponentially growing E.coli
K12 (ATCC, 106 CFU/mL). 20 mL of sample was diluted and
plated in LB-agar solid medium. Surviving bacteria were
quantified as CFU on plates after overnight incubation at 37uC.
Bacteria incubated in iPIPES without added proteins were
considered as controls.
Colitis and Colitis-associated colorectal cancer models
DSS-induced colitis was induced as previously described [26].
Daily changes in body weight were assessed. Rectal bleeding was
scored on a scale from 0 to 5, indicating no (0) or highly severe (5)
rectal bleeding. Ilea and colons were snap-frozen or fixed with 4%
Forma-Fixx (Thermo scientific) and embedded in paraffin. In vivo
intestinal permeability was examined in mice as described [27].
Colitis-induced colorectal cancer (AOM/DSS model) was induced
as previously described [28]. After sacrifice, mouse colons were
opened longitudinally and after 2 hours fixation in 4% Formal-
Fixx, briefly stained with Coomassie Blue to visualize tumors.
Tumors were counted in a blinded fashion by a pathologist.
Tumors size was assayed by gauge. Small pieces of terminal Ilea
and proximal colons were snap-frozen and the rest fixed with 4%
Forma-Fixx (Thermo scientific) and embedded in paraffin.
Statistical analysis
Data were checked with the Shapiro–Wilk test for normality in
R prior to performing significance tests. Variables with a W value
$0.80 were considered as approximately normally distributed.
Two variable comparisons were calculated using Welch’s two-
tailed t-test. For multiple comparisons, Bartlett’s test was
performed to check for equal variance (p.0.10) and then one-
way ANOVA was performed with the Bonferroni post-hoc test.
Variables with a Shapiro-Wilk W value ,0.80 were considered as
non-normal and comparisons were calculated using the Wilcoxon
signed-rank test. The Kaplan-Meier method was used for the
survival analysis in worms. Data are expressed as mean 6 SEM,
and for all significance comparisons, p values smaller than 0.05
were considered as statistically significant. *p,0.05; **p,0.01;
***p,0.001. This study had an exploratory nature and there was
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no pre-specified effect size. The sample size was chosen based on
the study feasibility and potential statistical power. Sample sizes
are consistent with those reported in similar studies. Statistical
analysis for the gut microbiota analysis is reported in the
Supplemental Information.
Results
Sirt1 deletion increases anti-microbial response in
mammals and nematodes
We first determined the localization of SIRT1 protein along the
villus/crypt axis. Since SIRT1 appears highly enriched in the
small intestine crypts (Figure S1A), we bred Villin-Cre transgenic
mice with mice in which exons 5–7 of the Sirt1 gene were flanked
by LoxP sites (Sirt1L2/L2) to generate intestinal-specific Sirt1
knockout mice (Sirt1int2/2) (Figure S1B–C). Unlike a previously
reported deletion of Sirt1 exon 4 [29], no truncated and potentially
active SIRT1 fragments were detected in Sirt1int2/2 mice (Figure
S1C). Sirt1int2/2 intestines showed a significant increase in the
number of Paneth (lysozyme+ and Defa4+) and goblet (PAS+), but
not of enteroendocrine (ChRA+) cells (Figure 1A, Figure S1D).
Accordingly, mRNA levels of Paneth (Lys, Crypt1, Crypt4, Defa-Rs)
and goblet (Klf4, Muc2) cell markers, as well as lysozyme protein
abundance and Defa4mRNA detected through in situ hybridization,
were induced in the proximal and distal intestine of Sirt1int2/2 mice
(Figures 1B–C, Figure S1D–E).
We next evaluated whether Sirt1 is correlated to the genes
involved in anti-bacterial defense using the BXD mouse genetic
reference population (www.genenetwork.org) [30]. As no intestinal
gene expression data are available, we analyzed hematopoietic
cells, which are part of the arsenal of cells that protect against
pathogens. In line with our observations, Sirt1 expression
correlates negatively with the expression of several Defensin-
related genes (Figure S1F).
To test whether the link between Sirt1 and the anti-bacterial
defense was evolutionary conserved, we used C. elegans. Remark-
ably, the expression of a wide range of genes involved in anti-
microbial defense (lyz-1, lyz-7, lyz-8) [31], as well as that of genes
induced by specific pathogens (F01D5.5, F56D6.2, C17H12.8,
C29F3.7, K08D8.5) [32] was enhanced in sir-2.1 [33] mutant
worms (Figure 1D). Furthermore, in lys-1::GFP and lys-7::GFP
reporter strains [31], sir-2.1 siRNA significantly induced both lys-
1- and lys-7-dependent GFP expression (Figure 1E). These data
hence indicate that the effect of Sirt1 in the anti-microbial response
is evolutionary conserved from mammals to worms.
Intestinal Sirt1 deletion impacts on gut microbiota
Considering the fundamental role that Paneth and goblet cells
play in protecting the mammalian gut from aberrant bacterial
colonization, we next analyzed the impact of a Sirt1 deletion on gut
microbiota. Sirt1int2/2 intestines did not only have a larger cecum
(Figure 2A), indicative of a modified microbiome [34], they also
had a higher bactericidal capacity (Figure 2B). Using DNA
extracted from either the intraluminal cecum content or colon
tissue, we amplified the V3 region of the bacterial 16S rRNA gene.
After removal of low quality reads and all singleton Operational
Taxonomic Units (OTUs) (Table S2 in File S1), 98% of the reads
fell into the Core Measurable Microbiome (CMM–see methods).
The microbial community was dominated by 4 phyla, Firmicutes,
Bacteroidetes, Proteobacteria, and Verrucomicrobia (Figure 2C) [35]. To
map the microbial community composition and structure across
the Sirt1 mutation we used an OTU-based method. In network-
based analyses, the cecum microbial communities of Sirt1L2/L2 and
Sirt1int2/2 mice highlighted community differences between
genotypes (Figure 2D), an observation further supported by
Principal Coordinates Analysis (PCA; Figure 2E). Indicator
microbial species that contribute towards community differences
between Sirt1L2/L2 and Sirt1int2/2 mice were identified and OTUs
displayed in Figure 2F and Table S3 in File S1. Interestingly, a
majority of enriched OTUs in Sirt1int2/2 mice were of the genus
Barnesiella, Bacteroides, and Prevotella (phylum Bacteroidetes), found in
the normal human and mouse gut, which are notably decreased in
IBD [36,37]. In contrast, the genus Clostridium (phylum Firmicutes)
was expanded in Sirt1L2/L2 mice (Figure 2F and Table S3 in File
S1). These results show that intestinal Sirt1 deletion and the
consequent changes in Paneth and goblet cells modify the gut
microbiome.
Intestinal Sirt1 deletion protects from colitis and
colitis-induced colorectal cancer
Given these last observations, we studied the impact of Sirt1 on
the pathogenesis of both colitis and CAC. Sirt1int2/2 mice,
exposed to dextran sulfate sodium (DSS), showed a milder colitis
characterized by lower body weight loss, bleeding score, a trend
towards reduced intestinal permeability, and a decreased expres-
sion of inflammatory genes (Figure S2A–D). These results incited
us to study how Sirt1int2/2 mice react to CAC. Mice were hence
injected with the AOM (azoxymethane) carcinogen before a
subsequent exposure to three cycles of DSS (Figure 3A). Remark-
ably, the number and size of tumors in Sirt1int2/2 intestines were
smaller (Figures 3A–B). The better health status of Sirt1int2/2 mice
was further underlined by the longer colon length and faster body
weight recovery after the last DSS cycle (Figures 3C–D).
Analysis of the microbial community after DSS/AOM exposure
revealed significant changes in Sirt1int2/2 mice (Figure 3E), while
the change was smaller in Sirt1L2/L2 mice (Figure 3F). Indicator
microbial species, before and after DSS/AOM, were identified
(Figures 3G–H and Table S4 in File S1). Of note, OTUs
belonging to genus Helicobacter and Desulfovibrio were only increased
after DSS/AOM in Sirt1L2/L2 mice (Figure 3G and Table S4 in
File S1). Interestingly, although the role of Helicobacter in colorectal
cancer remains controversial [38], Desulfovibrio is considered to take
part in the pathogenesis of ulcerative colitis and Crohn’s disease
[39]. Microbial communities in Sirt1L2/L2 and Sirt1int2/2 mice
after DSS/AOM treatment were not significantly different
(Figure 3I). Altogether, we hypothesize that changes in the general
microbial community under normal conditions (Figure 2), as well
as in specific genera after DSS/AOM, could determine the
different susceptibility of the two genotypes to colitis and CAC.
Hyper-acetylated SPDEF drives Paneth and goblet cell
maturation upon intestinal-specific Sirt1 deletion
To understand the molecular changes underlying these prom-
inent phenotypes, we explored different possible pathways that
contribute to Paneth and goblet cell development and maturation.
Since the intestinal cell types differentiate from intestinal stem cells
(ISC) [3], we first evaluated whether Sirt1 deletion might impact
the ISC population. In situ hybridization using RNA probes for
Olfm4, an ISC marker, failed to show differences in number and
localization of ISC between Sirt1int2/2 and Sirt1L2/L2 mice (Figure
S3A). By crossing Lgr5-EGFP-IRES-CreERT2 [40] with Sirt1int2/2 or
Sirt1L2/L2 mice, we generated a mouse line with an intestinal-
specific Sirt1 deletion, which concomitantly expresses GFP in ISCs.
FACS analysis of GFP-positive cells (Figure S3B), as well as
confocal imaging of crypts (Figure S3C), and gene expression
profiling (Figure S3D–E), revealed no differences in ISC number.
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We then analyzed the molecular pathways involved in intestinal
cell commitment. The Wnt/b-catenin signaling pathway is one of
the main driving forces of intestinal cell differentiation. Of note,
the relationship between b-catenin and SIRT1 has been exten-
sively studied in both mouse and cell lines, producing conflicting
results [11,12]. Neither the number nor the localization of
proliferative cells upon BrdU incorporation was different between
Sirt1int2/2 and Sirt1L2/L2 mice (Figure S4A). Accordingly, villi and
crypt lengths were indistinguishable (Figure S4B). Furthermore, no
SIRT1-dependent modulation of b-catenin levels or localization
could be observed by b-catenin immunostaining and protein
fractionation from crypts (Figure S4C–D). Thus, in our model
nothing heralds a possible involvement of b-catenin.
Paneth and goblet cells share also other transcription factors
downstream from the Notch and Wnt signaling cascades, such as
GIF1, SPDEF, and SOX9, which are required for their
differentiation [4,41,42]. Thus, we compared the expression of
their target genes in Sirt1int2/2 and control small intestines. Of
note, only SPDEF target genes, Slug, uPA, and Ccl6 [4,7], were
induced, but GIF1 (Nrg3, Pax6, ChgA) and SOX9 (Igfbp4) targets
were unchanged (Figure 4A), hinting to a possible involvement of
SPDEF. Since Spdef mRNA levels were not different between
Sirt1int2/2 and Sirt1L2/L2 mice (Figure 4A), we tested whether
SIRT1 alters SPDEF activity by modifying its acetylation status.
Among the three most important acetyltransferases, GCN5, P/
CAF, and p300, only the latter robustly acetylated SPDEF in vitro
(Figure 4B, lane 2). Interestingly, the observed SPDEF acetylation
was reversed by SIRT1 but not by the other nuclear sirtuins, such
as SIRT6 and SIRT7 (Figures 4B, lanes 3–5). Nano-LC-MS/MS
analysis identified the evolutionary conserved lysine residue K294
as the site that was deacetylated by SIRT1 (Figure 4C). We then
tested the SIRT1-dependence of SPDEF deacetylation in
Figure 1. SIRT1 deletion increases Paneth and goblet cell number and up-regulates anti-bacterial gene expression in mice and
worms. A, Representative images of Paneth (Lysozyme+ cells), goblet (Periodic acid-Shiff+ cells), and enteroendocrine (Chromogranin A+ cells) cell
staining. (N= 3 mice; 5–10 field per mouse, 50–100 crypt/villi per field). Bar = 50 mm. B–C, mRNA and protein levels of Paneth (Lys, Mmp7, Crypt1,
Crypt4, Defa-Rs) and goblet (Klf4, Muc2) markers are increased in the proximal and distal small intestine of Sirt1int2/2 mice (N= 6–8). For RTqPCR
analysis, rps12 was used as reference gene. b-Actin was used as loading control in the western blot. D, Increased expression of genes involved in
pathogen defense in the sir-2.1 (ok434) C. elegans mutant (N = 6; each N means a single population of ,500 worms). Act1 and Y45 were used as
reference. E, sir-2.1 siRNA induces lys-1 and lys-7 driven GFP expression in lys-1::GFP and lys-7::GFP reporter worms. In the same figure a representative
image of lys-7::GFP before and after sir-2.1 siRNA is shown (DIC, differential interference contrast). Results are expressed as mean6SEM. *P,0.05; **P,
0.01; ***P,0.001.
doi:10.1371/journal.pone.0102495.g001
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HEK293T cells co-transfected with SIRT1 or SIRT1G261A [16],
a catalytically inactive SIRT1 mutant. We also used a mutant of
SPDEF protein, in which the K294 lysine residue was replaced by
a glutamine (SPDEFK294Q), mirroring, at least in the charge, the
hyperacetylated status of SPDEF (Figure 4D). While SIRT1 was
able to fully deacetylate the wild type SPDEF, SIRT1G261A only
minimally affected SPDEF acetylation. Furthermore, the
SPDEFK294Q mutant was not acetylated, confirming that the
K294 is the key acetylation site (Figure 4D).
To understand how the acetylation status could affect SPDEF
activity, we assayed both wild type and SPDEFK294Q in protein
stability assays. Remarkably, in presence of cycloheximide, wild
type SPDEF deacetylation by SIRT1 significantly reduced its
stability (Figure 4E), while that of the SPDEFK294Q mutant was
not affected (Figure 4F). This change in the SPDEF protein
stability also influenced SPDEF transcriptional activity. Hence, the
presence of SIRT1 reduces the transcriptional activity of wild type
SPDEF on a cognate target reporter [17], but not that of the
SPDEFK294Q, which seems constitutively active (Figure 4G). For
technical reasons it was impossible to immune-precipitate SPDEF
and determine its acetylation status in vivo from mouse intestines,
but total protein quantification by western blot showed an increase
in the amount of total SPDEF in Sirt1int2/2 mice (Figure 4H).
SIRT1-dependent deacetylation of SPDEF hence reduces both its
stability and transcriptional activity. We can therefore assume that
SIRT1 deletion and the consequent SPDEF hyperacetylation,
stabilizes the SPDEF protein and increases its transcriptional
potential, ultimately favoring Paneth and goblet cells maturation.
Discussion
To bypass the pleiotropic effects of SIRT1 and focus on its
intestine-specific role, we generated a new intestine-specific Sirt1
mutant mouse model. Intestinal Sirt1 knockout mice have been
previously generated [10,11] through conditional deletion of Sirt1
exon 4, which encodes the catalytically active domain of the
protein. This strategy generates a truncated SIRT1 protein [29],
which has lost its enzymatic activities but still interacts with other
proteins, potentially confounding the interpretation of results. Our
model, in contrast, results in the full absence of SIRT1 in the
intestine, eliminating these possible confounders. The character-
ization of this new Sirt1int2/2 mouse line reveals an evolutionary
conserved process in which Sirt1 (or Sir-2.1) inactivation protects
the intestine from pathogens. This effect is, at least partially,
mediated by the hyperacetylation of SPDEF, which we identify as
a new SIRT1 deacetylation target. Acetylation stabilizes the
SPDEF and increases its capacity to enhance Paneth and goblet
cells differentiation and maturation, ultimately enhancing the
intestinal anti-bacterial potential and remodeling the gut micro-
biota.
Recently, an SPDEF-dependent increase of intestinal goblet
cells together with the inhibition of progenitor cells proliferation,
Figure 2. Intestinal deletion of Sirt1 rearranges the gut microbiome. A, Representative image showing a significant increase in cecum size in
Sirt1int2/2 mice. B, Bactericidal capacity of small intestine (duodenum) in Sirt1int2/2 and Sirt1L2/L2 mice was assayed by colony forming unit assay.
Results are expressed as % of the control (no proteins) (N = 7). C, Distribution of microbial Phyla in colon tissue and cecum contents of Sirt1L2/L2 and
Sirt1int2/2 mice. D, Network-based analyses of cecal bacterial communities in Sirt1L2/L2 and Sirt1int2/2mice. Each large circle represents an animal and
each smaller dot represents an OTU; Sirt1L2/L2 (Blue) and Sirt1int2/2 (Red). E, Principal Coordinate Analysis (PCA) (PERMANOVA p=0.012, and ANOSIM
p= 0.007) showing significant separation of the microbial communities between Sirt1L2/L2 and Sirt1int2/2 mice. F, Heatmap showing the top 20
different OTUs between Sirt1L2/L2 and Sirt1int2/2 mice. The abundance values were log transformed and standardized and plotted within matlab.
*indicates Barnesiella, Bacteroides, and Prevotella; 6indicates Clostridum genus (see also Table S3 in File S1). Results are expressed as mean6SEM. *P,
0.05; **P,0.01; ***P,0.001.
doi:10.1371/journal.pone.0102495.g002
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and a reduction in Paneth and enteroendocrine compartment has
been reported in a doxycycline-dependent intestinal-specific
SPDEF over-expressing mouse model [7,43]. These data, howev-
er, are in apparent contrast to the original characterization of the
SPDEF knockout mouse model [4], in which SPDEF deficiency
was responsible for both Paneth and goblet cells depletion, without
affecting epithelial cell proliferation. Moreover, doxycycline
treatment is known to heavily affect gut microbiota [44], hence
potentially affecting Paneth and goblet cells function and
maturation. Thus, the SPDEF-dependent increases of Paneth
and goblet cells observed in our model (Sirt1int2/2 mice) seems to
fit better with the original discovered role of SPDEF [4].
Furthermore, together with the Paneth and goblet cell number,
key antimicrobial peptides, such as lysozyme and the cryptidines,
are increased in the intestine of Sirt1int2/2 mice. The induction of
these genes and proteins enhances the bactericidal capacity of
Sirt1int2/2 crypt content, and most likely underlies the rearrange-
ment of the gut microbiome that we observed. SIRT1 in the
intestine was recently suggested to control ileal bile acid absorption
and as such impacts on systemic bile acid homeostasis [10]. In our
study, the expression of genes involved in bile acid transport and
sensing was, however, not altered, making changes in bile acids an
unlikely contributor to the altered gut flora (Figure S1E).
Importantly, our Sirt1int2/2 mice develop fewer tumors and
show milder inflammation after AOM/DSS. Previous studies on
the role of Sirt1 in colorectal cancer have used mice, in which the
exon 4 of Sirt1 was deleted [11] or in which Sirt1 was
overexpressed in the intestine [12]. The outcome of these studies
showed both tumor promoting and inhibiting effects related to
Sirt1 [11,12]. Besides the fact that we used a different Sirt1int2/2
mouse model, another notable difference between our work and
these studies is that they use Apcmin/+ mice. Apcmin/+ mice are
representative of hereditary and rare forms of colorectal cancer,
based on mutations in the APC gene. The sporadic form of
colorectal cancer, i.e. CAC, commonly found in the general
population, however, is better represented by the AOM/DSS
Figure 3. Intestinal Sirt1 deletion impacts on the development of colorectal cancer. A–B, Schematic representation of the AOM/DSS
protocol (top left panel) and representative image of colons from Sirt1int2/2 and control mice after CAC induction (Bar = 200 mm) (bottom left panel).
Sirt1int2/2 mice show significantly less tumors (right panel). B, Representative picture of a colon section from a Sirt1int2/2 and control mouse after
CAC induction (left panels). Tumor size (right panel). C, Colon length at the time of sacrifice (AOM/DSS). D, Percentage of body weight change. For
the AOM/DSS experiment 8 mice for each genotype were used. *P,0.05; **P,0.01; ***P,0.001. E–F, Principal Coordinate Analysis (PCA) of bacterial
sequences from colon tissue performed using unweighted UniFrac distance matrix. E, Sirt1int2/2 colon tissue before and after AOM treatment
(PERMANOVA p= 0.003, ANOSIM p=0.016). F, Sirt1L2/L2 colon tissue with and without AOM treatment (PERMANOVA p=0.067, ANOSIM p= 0.038).
G–H, Most statistically significant OTUs before and after AOM in both Sirt1L2/L2 (G), and Sirt1int2/2 (H), colon tissues; *Indicates Helicobacter and
Desulfovibrio (see also Table S4 in File S1). I, PCA of bacterial sequences from colon tissue after AOM (PERMANOVA p=0.767, ANOSIM p= 0.167).
doi:10.1371/journal.pone.0102495.g003
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mouse model. These previous studies using the APCmin/+ mouse
model furthermore showed conflicting results regarding the
involvement of the Wnt/b-catenin pathway. The reduction of
polyp number in a Sirt1 over-expressing APCmin/+ mouse model
was in one study attributed, to the inhibition of b-catenin, a
downstream target of the Wnt signaling [12], whereas another
study suggested that SIRT1 promotes the Wnt signaling both in
vitro and in vivo [11]. Our mouse model did not show differences in
intestinal cell proliferation, b-catenin activation/inhibition, and
intestinal stem cells involvement (Figure S3 and S4). However, a
growing body of evidence indicates that the possible role of SIRT1
in the Wnt signaling is complex and tightly related to possible
indirect mechanisms which involve other proteins, as well as
differences in cellular context [45,46,47,48].
Our results hence may be relevant for a large number of
subjects suffering from various forms of IBD and CAC and may
open a potential perspective to treat these conditions in which the
gut microbiota is involved by targeting SIRT1.
Supporting Information
Figure S1 Generation and characterization of Sirt1int2/2
mice. A, Villus/crypt fractionation shows a decrease in the
alkaline phosphatase (ALP) activity from the top of the villus (F1)
to the bottom (crypt, F5). SIRT1 shows a gradient increasing from
the top to the bottom of the villus/crypt unit. PCNA and LFABP,
respectively a proliferative and a differentiation marker, showed
opposite protein distribution, confirming the validity of the
fractionation protocol. Tubulin is the loading control. B,
Figure 4. Hyper-acetylation by SIRT1 stabilizes SPDEF and triggers Paneth and goblet cells maturation. A, SPDEF target genes (Slug,
uPA, Ccl6) are induced in Sirt1int2/2 intestines. GIF1 (Nrg3, Pax6, ChgA) and SOX9 (Igfbp4) target genes, as well as Spdef are not changed. B, In vitro
acetylation/deacetylation assays demonstrates that p300 acetylates SPDEF and SIRT1, but not SIRT6 and SIRT7, deacetylates SPDEF. C, Nano-LC-MS/
MS shows SIRT1-dependent in vitro deacetylation of AcK294 (left panel). Sequence alignment showing the evolutionary conserved K294 residue
(right panel). D, SIRT1, but not SIRT1G261A, deacetylates SPDEF in HEK293 immunoprecipitates. The SPDEFK294Q mutant is not acetylated. Tubulin
was used as loading control. E–F SPDEF, SPDEFK294Q, and SIRT1 were transfected in the HEK293 cell line and visualized by immunoblotting before
(0 min) and after cycloheximide (CHX) treatment. HSP90 is used as loading control (left panels in E and F). The relative stability of SPDEF or
SPDEFK294Q was calculated by ImageJ (right panels in E and F). G, PC3 cells were co-transfected with an E-Cadherin promoter luciferase reporter
construct, wild type or SPDEFK294Q in presence or absence of SIRT1. SIRT1 represses SPDEF-dependent reporter activation. The acetylated-mimic
SPDEFK294Q mutant is constitutively activate and not affected by SIRT1. H, Immunoblotting of crypt enriched fractions from Sirt1int2/2 and Sirt1L2/L2
mice show increased SPDEF protein levels in Sirt1int2/2 intestines. b-Actin was used as loading control. Results are expressed as mean6SEM. *P,0.05;
**P,0.01; ***P,0.001.
doi:10.1371/journal.pone.0102495.g004
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Schematic graph of the gene targeting strategy of exons 5–7 of the
Sirt1 gene. C Western blot analysis of SIRT1 expression in
intestine and liver of Sirt1int2/2 and control mice showing the
tissue-specific deletion of SIRT1. *Non-specific band. b-Actin is
the loading control. D, In situ hybridization using Defa4 RNA
probe to detect Paneth cells in Sirt1int2/2 and Sirt1L2/L2 mice. E,
RTqPCR analysis of bile acids transport and sensing mRNAs in
proximal and distal small intestine of Sirt1L2/L2 and Sirt1int2/2
mice (N= 6–8 mice). For RTqPCR analysis rps12 is used as
reference. F, inverse correlation between expression of Sirt1 (y-
axis) and mRNAs of each indicated defensin-related gene (x-axis)
in hematopoietic cells of BXD mice strains (N=22). Results are
expressed as mean6SEM.
(TIF)
Figure S2 Intestinal Sirt1 deletion impacts on the
development of colitis. A, Percentage of body weight loss
observed during 7 days of 2% DSS treatment. B, Rectal bleeding
score. Sirt1int2/2 mice show significant less weight loss and a
reduced bleeding score compared with wild type mice. Scoring
details are in Supplemental Materials & Methods. ANOVA
statistical analysis with Bonferroni post-hoc test was performed for
each time point. C, In vivo intestinal permeability measurement.
Sirt1int2/2 mice show a reduced FITC-derived fluorescence in the
blood suggesting less permeability, consequence of less inflamma-
tion. D, RT-qPCR analysis of lys, Crypt1, Tnfa, and Mcp1 mRNAs
in the distal ileum of Sirt1int2/2 and Sirt1L2/L2 after 2% DSS.
Cyclophilin is used as reference. For the colitis experiment, 8 mice
for each genotype were used. Results are expressed as mean6SEM.
*P,0.05; **P,0.01; ***P,0.001.
(TIF)
Figure S3 Intestinal Sirt1 deletion does not impact on
intestinal stem cells. A, Representative images of In situ
hybridization using RNA probes for Olfm4. B, Crypt from
Sirt1int2/2/Lgr5-EGFP-IRES-CreERT2 and Sirt1L2/L2/Lgr5EGFP-IRES-CreERT2
mice were isolated and GFP positive cells were detected by FACS
analysis. No changes are observed in the percentage of GFP
positive cells between the two groups (N=6). C, Representative
confocal images from Sirt1L2/L2/Lgr5EGFP-IRES-CreERT2 and Sirt1int2/2/
Lgr5-EGFP-IRES-CreERT2mice showingGFP+ ISC. Bar=50 mm.D,Gene
expression from the small intestine of Sirt1L2/L2/Lgr5EGFP-IRES-CreERT2
and Sirt1int2/2/Lgr5EGFP-IRES-CreERT2 mice shows no difference in
mRNA levels of ISC genes (Lgr5, Olfm4. Ascl2). E, RTqPCR analysis of
Lgr5,Olfm4, and Prom1mRNAs in proximal and distal small intestine of
wild type and Sirt1int2/2 mice. For RTqPCR analysis rps12 is used as
reference. Results are expressed as mean6SEM. *P,0.05; **P,0.01;
***P,0.001.
(TIF)
Figure S4 Proliferation assay and b-catenin detection in
Sirt1int2/2 and control mice. A, BrDu+ cell staining and
counts in Sirt1int2/2 and control mice 2, 24, and 48 hours after
injection. No differences are detected, highlighting the absence of
a change in proliferation (N= 3 mice per time point; 5–10 fields
per mouse/slide, 20–50 crypt/villi per field). Bar = 50 mm. B, Villi
and crypts length in Sirt1int2/2 and Sirt1L2/L2 (N= 9 mice. 5–10
fields per mouse, 20–50 crypt/villi per field). C, Immunostaining
of b-catenin in the ileum and colon of Sirt1int2/2 and control mice.
DAPI is used for nuclei staining. No differences are observed. D,
Proteins from isolated crypts of Sirt1int2/2 and Sirt1L2/L2 were
fractionated in order to detect b-catenin localization. No changes
between the two genotypes are observed. Protein quantification
was carried out trough ImageJ software (lower graph). Hsp90 is
used as loading and fractionation control (Cyto=Cytoplasm;
Nucl = nuclei).
(TIF)
File S1 Supplemental Materials and Methods and four
tables.
(DOC)
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